Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China
Clinical trial NCT00408993 · COMPLETED
Trial details
- NCT number
- NCT00408993
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-02-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.